Genomics England

Genomics England We’re working to enable faster and deeper genomic research, to bring genomic healthcare to all who need it.

Blood cancers are the fifth most common group of cancers in the UK. Genomics is changing how we diagnose and treat blood...
25/02/2026

Blood cancers are the fifth most common group of cancers in the UK. Genomics is changing how we diagnose and treat blood cancers, and for a small number of people, it is also revealing inherited risk. Finding out about inherited genetic changes can help guide treatment, support family members, and shape future care.

In our latest episode of Behind the Genes, we explore how genomics is helping families understand their risk and make informed decisions, and how genomic research is changing the future of care.

Listen on your favourite podcast app or on our website: https://ow.ly/IpSG50YlK5Y

For people living with rare conditions, genetic testing doesn’t always lead to immediate answers. Being told there are “...
24/02/2026

For people living with rare conditions, genetic testing doesn’t always lead to immediate answers. Being told there are “no primary findings” can be confusing and difficult.

In this Genomics 101 podcast, shared as part of our Rare Disease Day lead-up, we explain what this result means, and why ongoing research still matters.

Listen here:
https://ow.ly/NRxS50Yi0wv

Find the contact, social media, service desk, and other important information for Genomics England.

As we approach Rare Disease Day, we’re sharing resources that help build understanding of rare conditions and the experi...
23/02/2026

As we approach Rare Disease Day, we’re sharing resources that help build understanding of rare conditions and the experiences of people living with them.

In this Genomics 101 blog, we explain what a rare condition is, and how genomics plays a vital role in research, diagnosis and care.

Read the blog:
https://ow.ly/OgSF50Yi0uR

Genomics 101 goes back to basics to explore some important topics in genomics. This blog explains what we mean by 'rare conditions', how they are caused,…

For many people with rare conditions, diagnosis can take years. This long and uncertain journey is often called the diag...
20/02/2026

For many people with rare conditions, diagnosis can take years. This long and uncertain journey is often called the diagnostic odyssey.

As we approach Rare Disease Day, our Genomics 101 blog explores what the diagnostic odyssey is, the impact it can have on people and families, and how genomics is helping to shorten this journey.

Read the blog:
https://www.genomicsengland.co.uk/blog/genomics-101-what-is-the-diagnostic-odyssey

In this series, ‘Genomics 101’, we go back to basics and explore some of the most important topics in genomics. In this blog, we explain what it means to…

For people on a diagnostic journey for their rare condition, the results can be complex and uncertain. One of the most c...
19/02/2026

For people on a diagnostic journey for their rare condition, the results can be complex and uncertain. One of the most common terms you may come across is a variant of uncertain significance (VUS).

As part of our Rare Disease Day lead-up, this Genomics 101 podcast explains what a VUS is, why uncertainty exists, and how results can change over time as research advances.

Listen on your favourite podcast app or our website:
https://ow.ly/qxxB50Yi0gI

Find the contact, social media, service desk, and other important information for Genomics England.

The 2026 Genomics England Research Summit programme is now live.Explore the sessions and speakers, and secure your place...
18/02/2026

The 2026 Genomics England Research Summit programme is now live.

Explore the sessions and speakers, and secure your place: https://ow.ly/rlrM50Yhup0

Applications are still open for Participant Panel members and a Vice-Chair for cancer, until Sunday 8 March, 11:59pm.The...
16/02/2026

Applications are still open for Participant Panel members and a Vice-Chair for cancer, until Sunday 8 March, 11:59pm.

The Panel plays a vital role in ensuring the voices of participants and their families inform everything Genomics England does. Panel members provide guidance and advice to Genomics England, including on the use of genomic medicine within the NHS.

The Panel is made up of a diverse group of people with a range of lived experiences who have consented for their de-identified genomic data, or the data of someone they care for, to be held in the National Genomic Research Library (NGRL). This enables research to improve the diagnosis and treatment of rare conditions and cancer.

For more information and how to apply visit: https://www.genomicsengland.co.uk/patients-participants/participant-panel/join

To mark Rare Disease Day, we’ve brought together a collection of blogs, podcasts, personal stories and other helpful res...
12/02/2026

To mark Rare Disease Day, we’ve brought together a collection of blogs, podcasts, personal stories and other helpful resources.

These pieces explore the impact that rare conditions can have on people’s lives, sharing lived experiences alongside insights into research, diagnosis and care. They also highlight how we at Genomics England work with participants, families, researchers and the NHS, to support the rare conditions community.

Visit the page to explore the collection and learn more: https://ow.ly/NEOe50Yc7cy

11/02/2026

What do we mean by informed consent?

Réka Novotta, Research Ethics Operations Manager at Genomics England, joins our latest Genomics 101 episode to explain.

Genomics 101's are our bitesize podcast episodes, all less than 10 minutes long, which explain terms you may come across in genomics.

Listen on your favourite podcast app or on our website: https://ow.ly/5qKt50YcNZS

"We believe the benefits of genomic medicine should be able to reach everyone – and this requires appreciating that ever...
06/02/2026

"We believe the benefits of genomic medicine should be able to reach everyone – and this requires appreciating that everyone has different needs to start with."

Natalie Banner, Chief Ethics and Engagement Officer for Genomics England, shares how we can work towards equity in rare conditions in the latest blog, linked below.
https://ow.ly/4zMT50Y9atE

04/02/2026

Last week we shared our latest podcast episode, a live recording from our 2025 Research Summit, where our guests discussed what it's like to navigate long, uncertain and often emotional journey to a genetic diagnosis.

Listen on your favourite podcast app, or on our website: https://ow.ly/1mha50Y88aK

The Participant Panel at Genomics England is seeking new members, and a Vice-Chair for Cancer. The Panel plays a vital r...
02/02/2026

The Participant Panel at Genomics England is seeking new members, and a Vice-Chair for Cancer. The Panel plays a vital role in ensuring the voices of participants and their families inform everything Genomics England does. Panel members provide guidance and advice to Genomics England, including on the use of genomic medicine within the NHS.

The Panel is made up of a diverse group of people with a range of lived experiences who have consented for their de-identified genomic data, or the data of someone they care for, to be held in the National Genomic Research Library (NGRL). This enables research to improve the diagnosis and treatment of rare conditions and cancer.

Applications close on Sunday 8 March, 11:59pm.

For more information and how to apply visit: https://www.genomicsengland.co.uk/patients-participants/participant-panel/join

Address

One Canada Square
London
E145AB

Alerts

Be the first to know and let us send you an email when Genomics England posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram